These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 16525132

  • 1. Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells.
    Zhang L, Tetrault J, Wang W, Loh HH, Law PY.
    Mol Pharmacol; 2006 Jun; 69(6):1810-9. PubMed ID: 16525132
    [Abstract] [Full Text] [Related]

  • 2. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY, Bergsbaken C.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [Abstract] [Full Text] [Related]

  • 3. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S, Polastron J, Hasbi A, Homburger V, Jauzac P.
    Biochem J; 1999 Aug 15; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [Abstract] [Full Text] [Related]

  • 4. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R, Díaz A, Valdizán EM, Rodríguez-Muñoz M, Garzón J, Hurlé MA.
    Neuropharmacology; 2008 May 15; 54(6):989-97. PubMed ID: 18384820
    [Abstract] [Full Text] [Related]

  • 5. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL, Tsai AW, Law PY.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):177-84. PubMed ID: 8035314
    [Abstract] [Full Text] [Related]

  • 6. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ, Traynor JR.
    J Pharmacol Exp Ther; 2005 Feb 15; 312(2):809-15. PubMed ID: 15383633
    [Abstract] [Full Text] [Related]

  • 7. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation.
    Chakrabarti S, Yang W, Law PY, Loh HH.
    Mol Pharmacol; 1997 Jul 15; 52(1):105-13. PubMed ID: 9224819
    [Abstract] [Full Text] [Related]

  • 8. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
    Murthy KS, Makhlouf GM.
    Mol Pharmacol; 1996 Oct 15; 50(4):870-7. PubMed ID: 8863832
    [Abstract] [Full Text] [Related]

  • 9. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
    Clark MJ, Neubig RR, Traynor JR.
    J Pharmacol Exp Ther; 2004 Jul 15; 310(1):215-22. PubMed ID: 15014136
    [Abstract] [Full Text] [Related]

  • 10. Agonist Activity of the delta-antagonists TIPP and TIPP-psi in cellular models expressing endogenous or transfected delta-opioid receptors.
    Martin NA, Terruso MT, Prather PL.
    J Pharmacol Exp Ther; 2001 Jul 15; 298(1):240-8. PubMed ID: 11408548
    [Abstract] [Full Text] [Related]

  • 11. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
    Yoshimura M, Ikeda H, Tabakoff B.
    Mol Pharmacol; 1996 Jul 15; 50(1):43-51. PubMed ID: 8700117
    [Abstract] [Full Text] [Related]

  • 12. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May 15; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

  • 13. delta-Opioid receptors are more efficiently coupled to adenylyl cyclase than to L-type Ca(2+) channels in transfected rat pituitary cells.
    Prather PL, Song L, Piros ET, Law PY, Hales TG.
    J Pharmacol Exp Ther; 2000 Nov 15; 295(2):552-62. PubMed ID: 11046088
    [Abstract] [Full Text] [Related]

  • 14. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
    Tso PH, Wong YH.
    J Pharmacol Exp Ther; 2000 Oct 15; 295(1):168-76. PubMed ID: 10991975
    [Abstract] [Full Text] [Related]

  • 15. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Prather PL, Loh HH, Law PY.
    Mol Pharmacol; 1994 May 15; 45(5):997-1003. PubMed ID: 8190115
    [Abstract] [Full Text] [Related]

  • 16. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR, Fleming LM, Selley DE, McNutt RW, Chang KJ.
    Mol Pharmacol; 1993 Oct 15; 44(4):827-34. PubMed ID: 8232233
    [Abstract] [Full Text] [Related]

  • 17. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
    Clark MJ, Traynor JR.
    Methods Enzymol; 2004 Oct 15; 389():155-69. PubMed ID: 15313565
    [Abstract] [Full Text] [Related]

  • 18. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
    Chern Y, Lai HL, Fong JC, Liang Y.
    Mol Pharmacol; 1993 Nov 15; 44(5):950-8. PubMed ID: 8246918
    [Abstract] [Full Text] [Related]

  • 19. Inverse agonistic effect of ICI-174,864 on the cloned delta-opioid receptor: role of G protein and adenylyl cyclase activation.
    Chiu TT, Yung LY, Wong YH.
    Mol Pharmacol; 1996 Dec 15; 50(6):1651-7. PubMed ID: 8967989
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
    Li Y, Hashim S, Anand-Srivastava MB.
    Cardiovasc Res; 2005 Jun 01; 66(3):503-11. PubMed ID: 15914115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.